| Literature DB >> 29518093 |
Runjun Dowarah1, Ashok Kumar Verma1, Neeta Agarwal1, Putan Singh1, Bhoj Raj Singh2.
Abstract
The present study was aimed to develop an effective probiotic lactic acid bacteria (LAB) from piglet feces and in vitro characterization of probiotic properties. To confirm host-species specificity of probiotics, the efficacy of isolated LAB on growth, nutrient utilization, health and antioxidant status was observed in early weaned piglets. A total of 30 LAB were isolated from feces of five healthy piglets (28d old). All isolates were Gram positive, cocco-bacilli and catalase negative. Out of thirty LAB isolates, twenty were shortlisted on the basis of their tolerance to pH (3.0, 4.0, 7.0 and 8.0) and bile salts (0.075, 0.15, 0.3 and 1.0%). Whereas, fourteen isolates were selected for further in vitro probiotic characterization due higher (P<0.05) cell surface hydrophobicity to toluene (>45 percent). These isolates fermented twenty-seven different carbohydrates but were negative for ONPG, citrate and malonate. Also enabled to synthesize amylase, protease, lipase and phytase. They were sensitive to penicillin, azithromycin, lincomycin, clindamycin, erythromycin, cephalothin and chloramphenicol and resistant to ciprofloxacin, ofloxacin, gatifloxacin, vancomycin and co-trimoxazole. Except three isolates, all showed antagonistic activity (>60% co-culture activity) against Escherichia coli, Salmonella Enteritidis, Salmonella serotype (ser.) Typhimurium, Staphylococcus intermedius, Staph. chromogenes, Proteus mirabillis, Areomonas veonii, Bordetella bronchioseptica and Klebsialla oxytoca. The isolate Lacp28 exhibited highest tolerance to acidic pH and bile salts (up to 0.3%), phytase activity, cell surface hydrophobicity, antagonistic activity and co-culture assay (>80% growth inhibition). Host specificity of Lacp28 was further confirmed by heavy in vitro adhesion to pig intestinal epithelium cells compared to chicken. Hence, Lacp28 was selected and identified by phylogenetic analysis of 16S rRNA as Pediococcus acidilactici strain FT28 with 100% similarity (GenBank accession nos. KU837245, KU837246 and KU837247). The Pediococcus acidilactici FT28 was selected as potential probiotic candidature for in vivo efficacy in weaned pigs. Thirty-six crossbred piglets (28d) were randomly distributed into three groups (four replicates of three each) namely, basal diet without probiotics (T0) or with Lactobacillus acidophilus NCDC15 (conventional dairy-specific probiotic; T1) or Pediococcus acidilactici FT28 (swine-specific probiotic; T2). At end of the experiment, six piglets of similar body weight were selected to conduct digestion trial for estimation of nutrient digestibility. Results of the study indicated that supplementation of both probiotics improved (P<0.001) FCR compared to control without significant effect in average daily gain and DM intake. However, the apparent digestibility of crude protein and ether extract was better (P<0.01) in pigs fed P. acidilactici FT28 compared control and L. acidophilus fed groups. The total WBC and RBC count, serum glucose, total protein, albumin and globulin concentration was higher (P<0.05) in P. acidilactici FT28 fed group with better (P<0.05) catalase and superoxide dismutase activity measured in erythrocyte. It is concluded that species-specific Pediococcus acidilactici FT28 isolated with potential in vitro probiotic properties and also hold probiotic candidature by showing the potential capabilities with higher nutrient digestibility, heamato-biochemical and antioxidant status compared to control and Lactobacillus acidophilus NCDC15.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29518093 PMCID: PMC5843174 DOI: 10.1371/journal.pone.0192978
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers and their sequences used for amplification of 16S rRNA and rDNA gene.
| Target microbes | Sequence (5’-3’) | Annealing temp (oC) | Product (bp) | References |
|---|---|---|---|---|
| Universal bacteria | 50 | 1500 | [ | |
| Lactobacillus | 56 | 1200 | [ | |
| Lactobacillus | 56 | 700 | [ |
Ingredient and chemical composition (% DM) of the experimental basal diets.
| Attributes | Body weights (kg) | |||
|---|---|---|---|---|
| 5–10 | 10–20 | 20–50 | ||
| Crushed maize | 46 | 54 | 62 | |
| Deoiled soybean meal | 30 | 22 | 15 | |
| Wheat bran | 16 | 16 | 15 | |
| Fish meal | 06 | 06 | 06 | |
| Mineral mixture | 1.5 | 1.5 | 1.5 | |
| Common salt | 0.5 | 0.5 | 0.5 | |
| DM | 90.20 | 90.25 | 90.40 | |
| OM | 91.27 | 91.66 | 92.37 | |
| CP | 23.22 | 20.99 | 18.59 | |
| EE | 2.39 | 3.09 | 3.80 | |
| CF | 4.31 | 4.55 | 4.72 | |
| Total ash | 8.73 | 8.34 | 7.63 | |
| NFE | 61.35 | 63.03 | 65.26 | |
| Calcium | 0.82 | 0.71 | 0.62 | |
| Phosphorous | 0.63 | 0.61 | 0.55 | |
| GE (Mcal/kg) | 4.16 | 4.17 | 4.17 | |
*Each 250 g contain: vitamin A 5,00,000IU; vitamin D3 1,00,000IU; vitamin B2 0.2g; vitamin E 75mg; vitamin K 0.1g; vitamin B12 600mcg; calcium pantothenate 25mg; niacin 1g; choline chloride 15g; calcium 70g; manganese 2.75g; iodine 0.1g; iron 0.75g; zinc 1.5g; copper 0.2g; cobalt 0.045g; phosphorus 20g.
Fig 1Growth of the LAB isolates (n = 20) at varied pH and bile salt, respectively after 6h incubation at 37°C.
Fig 2Cell surface hydrophobicity assay (%) of LAB isolates.
Enzymatic activities of LAB isolates in different agar medium (at 37°C for 48h).
| Isolates | Diameter of halo zone | |||
|---|---|---|---|---|
| Amylase | Protease | Lipase | Phytase | |
| Lacp03 | 4.75 | 4.75 | 10.75 | 16.50 |
| Lacp13 | 5.00 | 0.00 | 10.00 | 17.75 |
| Lacp16 | 5.50 | 6.75 | 10.25 | 17.25 |
| Lacp17 | 5.75 | 0.00 | 10.00 | 20.00 |
| Lacp18 | 5.75 | 8.00 | 11.50 | 16.50 |
| Lacp20 | 4.75 | 8.75 | 10.50 | 15.75 |
| Lacp21 | 5.50 | 8.00 | 10.25 | 19.00 |
| Lacp23 | 5.00 | 10.50 | 10.75 | 16.00 |
| Lacp24 | 5.25 | 7.25 | 10.75 | 17.50 |
| Lacp25 | 6.00 | 10.25 | 10.50 | 16.25 |
| Lacp26 | 5.50 | 10.00 | 10.75 | 16.25 |
| Lacp27 | 6.00 | 8.50 | 11.25 | 17.00 |
| Lacp28 | 6.25 | 9.75 | 10.25 | 21.00 |
| Lacp30 | 6.50 | 8.50 | 10.25 | 20.50 |
| SEM | 0.13 | 0.45 | 0.09 | 0.27 |
| P value | 0.293 | <0.001 | 0.069 | <0.001 |
† Mean of three observations each
abcdefMeans bearing different superscripts in a column differ significantly (P<0.05)
Resistance of the selected LAB isolates to various antibiotics (Hi-Media).
| Antibiotics | Disc content | Isolates No | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CIP | 5 μg | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| OF | 5 μg | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| GAT | 5 μg | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| P | 2 unit | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| AZM | 15 μg | I | S | S | S | S | S | S | S | S | S | S | I | S | I |
| L | 10 μg | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| VA | 30 μg | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| CD | 2 μg | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| E | 10 μg | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| GEN | 10 μg | R | I | I | R | I | I | I | I | I | I | I | I | I | I |
| TE | 10 μg | S | I | I | I | I | I | S | I | I | I | I | S | I | S |
| DO | 30 μg | I | I | I | I | I | I | I | I | I | I | I | I | I | I |
| COX | 5 μg | I | R | R | I | R | R | I | R | I | I | I | I | I | I |
| AMP | 10 μg | I | I | I | I | S | I | I | I | I | I | I | I | S | I |
| OX | 1 μg | I | I | I | S | I | I | I | I | I | I | I | I | I | S |
| COT | 25 μg | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| CXM | 30 μg | S | R | I | I | I | I | I | R | I | I | I | I | R | I |
| CEP | 30 μg | S | I | I | S | S | S | S | S | S | S | S | S | S | S |
| C | 30 μg | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
CIP, ciprofloxacin; OF, ofloxacin; GAT, gatifloxacin; P, penicillin-G; AZM, azithromycin; L, lincomycine; VA, vancomycin; CD, clindamycin; E, erythomycine; GEN, gentamycin; TE, tetracycline; DO, doxycycline hydrochloride; COX, cloxacillin; AMP, ampicillin; OX, oxacillin; COT, co-trimoxazole; CH, cefradine; CXM, cefuroxime; CEP, cephalothin; C, chloramphenicol
Antagonistic activity (diameter of inhibition zone; mm) of selected LAB isolates against pathogenic bacteria (at 37°C for 24h).
| Diameter of inhibition zone | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Lacp03 | 10.33 | 12.33 | 13.67 | 11.00 | 10.33 | 9.67 | 0.00 | 9.00 | 14.33 |
| Lacp13 | 13.33 | 11.67 | 12.00 | 15.00 | 13.67 | 12.33 | 12.33 | 13.67 | 8.00 |
| Lacp16 | 13.67 | 10.67 | 13.00 | 16.33 | 12.67 | 10.33 | 14.67 | 12.33 | 12.00 |
| Lacp17 | 12.67 | 12.00 | 11.67 | 16.67 | 14.33 | 12.67 | 13.33 | 13.33 | 10.67 |
| Lacp18 | 12.00 | 12.00 | 12.33 | 13.00 | 13.33 | 10.00 | 13.67 | 11.00 | 10.67 |
| Lacp20 | 12.00 | 12.00 | 13.33 | 16.00 | 13.00 | 13.00 | 10.67 | 11.67 | 10.33 |
| Lacp21 | 12.00 | 13.00 | 14.00 | 9.33 | 15.33 | 13.67 | 12.33 | 10.67 | 10.33 |
| Lacp23 | 11.67 | 12.67 | 13.67 | 11.33 | 12.00 | 15.00 | 12.00 | 12.33 | 11.00 |
| Lacp24 | 12.67 | 13.00 | 14.67 | 14.00 | 13.33 | 13.00 | 14.00 | 12.00 | 12.67 |
| Lacp25 | 12.00 | 12.67 | 14.33 | 17.67 | 14.00 | 11.00 | 14.67 | 10.00 | 11.00 |
| Lacp26 | 13.67 | 11.67 | 12.67 | 14.00 | 15.00 | 13.33 | 13.00 | 12.00 | 12.00 |
| Lacp27 | 12.67 | 11.00 | 13.67 | 11.00 | 14.67 | 10.33 | 10.00 | 0.00 | 10.67 |
| Lacp28 | 13.67 | 12.6 | 15.67 | 22.67 | 15.67 | 14.00 | 13.00 | 14.00 | 13.67 |
| Lacp30 | 11.67 | 11.00 | 10.33 | 19.33 | 15.33 | 14.00 | 0.00 | 10.67 | 14.00 |
| SEM | 0.17 | 0.13 | 0.22 | 0.58 | 0.23 | 0.27 | 0.73 | 0.52 | 0.27 |
| P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
†Mean of three observations each
abcdefghMeans bearing different superscripts in a column differ significantly (P<0.01)
Co-culture assay (inhibition percentage) of LAB isolates against various pathogens (at 37°C for 24h).
| Isolate Nos. | Growth inhibition of pathogenic bacteria | ||||||
|---|---|---|---|---|---|---|---|
| Lacp03 | 52.90 | 75.31 | 66.13 | 58.98 | 57.20 | 72.11 | 76.19j |
| Lacp13 | 73.33 | 69.63 | 75.47 | 75.64 | 67.69 | 87.30 | 48.94 |
| Lacp16 | 77.63 | 81.23 | 76.80 | 62.82 | 62.55 | 81.18 | 61.64 |
| Lacp17 | 66.24 | 70.86 | 77.07 | 79.49 | 67.28 | 83.22 | 43.39 |
| Lacp18 | 62.58 | 70.62 | 69.33 | 68.72 | 62.14 | 75.28 | 53.70 |
| Lacp20 | 62.15 | 70.86 | 75.20 | 64.36 | 69.34 | 77.78 | 51.59 |
| Lacp21 | 62.15 | 82.22 | 64.00 | 83.08 | 70.99 | 74.60 | 52.38 |
| Lacp23 | 56.56 | 76.54 | 66.40 | 64.36 | 75.93 | 81.86 | 58.73 |
| Lacp24 | 67.74 | 64.44 | 73.33 | 74.36 | 72.016 | 78.68 | 65.61 |
| Lacp25 | 63.01 | 77.28 | 80.27 | 77.69 | 67.28 | 72.34 | 60.32 |
| Lacp26 | 79.35 | 70.37 | 75.20 | 82.82 | 71.19 | 79.37 | 64.55 |
| Lacp27 | 65.81 | 68.64 | 66.13 | 80.51 | 63.17 | 68.71 | 54.50 |
| Lacp28 | 83.01 | 80.49 | 86.93 | 87.44 | 74.07 | 90.48 | 73.016 |
| Lacp30 | 56.56 | 68.15 | 78.93 | 84.36 | 74.49 | 75.06 | 74.87 |
| SEM | 1.37 | 0.84 | 0.99 | 8.99 | 0.83 | 0.92 | 1.51 |
| P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
†Mean of three observations each
abcdefghijMeans bearing different superscripts in a column differ significantly (P<0.05)
Fig 3Phylogenetic tree prepared by Clustal V method for molecular identification of Lacp28 with different primers a) 27F/1492R; b) LpigF/LpigR and c) S-17F/ A-17R.
Fig 4In vitro adhesion of the isolates (Lacp28) to epithelium cells of pig's ileum (a) and chicken intestine (b) after treatment with cell suspension (1x109 cfu/ml). Magnification, X400.
Effect of probiotics on growth performance and nutrient digestibility in early weaned crossbred pigs.
| Weeks | Dietary treatments | SEM | P value | ||
|---|---|---|---|---|---|
| T0 | T1 | T2 | |||
| IBW (kg) | 7.43 | 7.05 | 8.06 | 0.23 | 0.215 |
| FBW (kg) | 44.08 | 44.83 | 47.35 | 0.92 | 0.362 |
| ADG (g/d) | 402.8 | 415.2 | 431.7 | 8.96 | 0.429 |
| DMI (g/d) | 1023 | 936.7 | 928.8 | 21.0 | 0.124 |
| FCR | 2.55 | 2.26 | 2.16 | 0.06 | 0.010 |
| Dry matter | 82.85 | 80.83 | 81.55 | 1.13 | 0.686 |
| Organic matter | 81.85 | 81.46 | 83.08 | 0.61 | 0.556 |
| Crude protein | 74.85 | 75.96 | 81.86 | 1.08 | 0.008 |
| Crude fibre | 30.24 | 35.96 | 50.24 | 3.29 | 0.042 |
| Ether extract | 59.93 | 62.02 | 67.28 | 3.30 | 0.308 |
No probiotics (T0), L. acidophilus (T1) and P. acidilactici FT28 (T2)
ab Means with different superscript within a row differ significantly. IBW; initial body weight, FBW; final body weight, ADG; Average daily gain, DMI; dry matter intake, FCR; feed conversion ratio
Fig 5Effect of probiotics on red blood cells (RBC; 1012/L), white blood cells (WBC; 109/L) and haemoglobin (Hb; g/dL) percentage in crossbred weaning pigs.
Effect of feeding different probiotic source in blood biochemical and antioxidant profile on early weaned crossbred pigs.
| Treatment | Period | Mean | SEM | Significance | |||
|---|---|---|---|---|---|---|---|
| Day 45 | Day 90 | T | P | T*P | |||
| T0 | 71.75 | 65.91 | 68.85 | 3.29 | <0.001 | 0.010 | 0.015 |
| T1 | 68.06 | 89.03 | 78.54 | 3.29 | |||
| T2 | 91.63 | 107.8 | 100.3 | 3.41 | |||
| T0 | 5.65 | 6.08 | 5.87 | 0.19 | <0.001 | 0.017 | 0.106 |
| T1 | 5.07 | 5.13 | 5.10 | 0.19 | |||
| T2 | 7.65 | 8.79 | 8.26 | 0.19 | |||
| T0 | 3.67 | 3.42 | 3.55 | 0.10 | <0.001 | 0.017 | 0.006 |
| T1 | 2.57 | 2.97 | 2.77 | 0.10 | |||
| T2 | 3.29 | 3.99 | 3.66 | 0.10 | |||
| T0 | 1.98 | 2.66 | 2.32 | 0.20 | <0.001 | 0.378 | 0.100 |
| T1 | 2.61 | 2.10 | 2.35 | 0.20 | |||
| T2 | 4.36 | 4.82 | 4.60 | 0.21 | |||
| T0 | 46.83 | 38.75 | 42.79 | 3.08 | 0.287 | 0.064 | 0.075 |
| T1 | 46.61 | 29.96 | 38.28 | 3.08 | |||
| T2 | 33.69 | 37.93 | 35.95 | 3.19 | |||
| T0 | 1.26 | 1.20 | 1.23 | 0.05 | 0.001 | <0.001 | <0.001 |
| T1 | 1.19 | 1.73 | 1.46 | 0.05 | |||
| T2 | 1.34 | 1.69 | 1.53 | 0.05 | |||
| T0 | 60.99 | 49.02 | 55.01 | 4.00 | 0.030 | 0.227 | 0.639 |
| T1 | 68.41 | 65.74 | 67.08 | 4.00 | |||
| T2 | 74.15 | 68.62 | 69.80 | 4.14 | |||
| T0 | 71.24 | 131.6 | 101.4 | 5.59 | 0.018 | <0.001 | 0.421 |
| T1 | 74.42 | 155.5 | 114.9 | 5.59 | |||
| T2 | 91.67 | 159.1 | 127.6 | 5.79 | |||
No probiotics (T0), L. acidophilus (T1) and P. acidilactici FT28 (T2)
abcMeans with different superscript within a column differ significantly
‡Significant effects of dietary treatment (T), period (P) or their interaction (T*P)